Postoperative ctDNA in Resectable Esophageal Squamous Cell Carcinoma: From Molecular Residual Disease Detection Toward Risk-Adapted Adjuvant Therapy and Surveillance

Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, Koshi Fujikawa

Open source

DOI
10.1007/s12029-026-01635-3
Published
2026-11-06
Container
Journal of Gastrointestinal Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12029-026-01635-3,
  title = {Postoperative ctDNA in Resectable Esophageal Squamous Cell Carcinoma: From Molecular Residual Disease Detection Toward Risk-Adapted Adjuvant Therapy and Surveillance},
  author = {Tamotsu Sagawa and Masahiro Hirakawa and Hiroyuki Nagashima and Koshi Fujikawa},
  year = {2026},
  journal = {Journal of Gastrointestinal Cancer},
  doi = {10.1007/s12029-026-01635-3},
  url = {https://doi.org/10.1007/s12029-026-01635-3}
}

RIS

TY  - JOUR
TI  - Postoperative ctDNA in Resectable Esophageal Squamous Cell Carcinoma: From Molecular Residual Disease Detection Toward Risk-Adapted Adjuvant Therapy and Surveillance
AU  - Tamotsu Sagawa
AU  - Masahiro Hirakawa
AU  - Hiroyuki Nagashima
AU  - Koshi Fujikawa
PY  - 2026
JO  - Journal of Gastrointestinal Cancer
DO  - 10.1007/s12029-026-01635-3
UR  - https://doi.org/10.1007/s12029-026-01635-3
ER  - 

APA

Sagawa, T., Hirakawa, M., Nagashima, H., & Fujikawa, K. (2026). Postoperative ctDNA in Resectable Esophageal Squamous Cell Carcinoma: From Molecular Residual Disease Detection Toward Risk-Adapted Adjuvant Therapy and Surveillance. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-026-01635-3

Source records